2021-2022 Funded Research

Funded Research for 2021-2022

George C. Cotzias Fellowship

The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.


Abby L. Olsen, MD, PhD

The Brigham and Women’s Hospital, Boston, MA
Harnessing the untapped therapeutic potential of glia in Parkinson’s disease


 


Diversity in Parkinson’s Disease Research Grant

The Diversity in Parkinson’s Disease Research Grant is awarded to an investigator studying the health disparities or differences among under-represented PD communities.


Jennifer G. Goldman, MD, MS

Shirley Ryan AbilityLab, Chicago, IL
Understanding utilization of rehabilitation services across diverse populations


Miguel E. Rentería, PhD

Red Mexicana de Bioinformática, Cuernavaca, Morelos, Mexico
Clinical, epidemiological, and cognitive characterization of Parkinson’s disease in the Mexican population


 


Post-Doctoral Fellowships

This fellowship is awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD.

Rachel A. Coleman, PhD

University of Alabama at Birmingham, Birmingham, AL
LRRK2 regulation of glucocerebrosidase activity: role of Rab10 and pathological characterization


Enrico Opri, PhD

Emory University, Atlanta, GA
DBS-induced local evoked potentials for asleep intraoperative functional mapping


Leonardo Parra-Rivas, PhD

University of California San Diego, San Diego, CA
Evaluating α-synuclein pathophysiology in human neurons

 


Research Grants

This grant is awarded to investigators performing innovative PD research at major academic institutions across the United States.

Constanza J. Cortes, PhD

University of Alabama at Birmingham, Birmingham, AL
Exercise-Mimetics: novel neuroprotectant pathways in Parkinson disease


Xianjun Dong, PhD

The Brigham and Women’s Hospital, Boston, MA
Developing RNA biomarkers of early PD pathology from brain organoids and extracellular vesicles


Rebekah Evans, PhD

Georgetown University, Washington DC
Defining circuit alterations that influence dopaminergic neuron vulnerability in early Parkinson’s disease


Rafiq Huda, PhD

Rutgers University, New Brunswick, NJ
Harnessing astrocyte neuromodulation for alleviating the motor symptoms of Parkinson’s disease


Sunil Kumar, PhD

University of Denver, Denver, CO
Identification of novel targets associated with α-synuclein aggregation


Huiliang Wang, PhD

University of Texas at Austin, Austin, TX
Sono-optogenetic stimulation for Parkinson disease treatment in rats



IN THE NEWS

APDA Awards $1.85 Million in Research Grants. 

Click here to read the Press Release